Green Thumb Industries (GTBIF) Income from Non-Controlling Interests (2019 - 2026)
Green Thumb Industries (GTBIF) reported Income from Non-Controlling Interests of -$350000.0 for Q1 2026, down 468.42% on a YoY basis from $95000.0 in Q1 2025, and down 316.67% quarter-over-quarter from -$84000.0 in Q4 2025.
Green Thumb Industries (GTBIF) Income from Non-Controlling Interests (2019 - 2026) Analysis & Trends
Green Thumb Industries has reported Income from Non-Controlling Interests for 8 years, with the latest figure at -$350000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Non-Controlling Interests fell 468.42% year-over-year to -$350000.0; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (up 146.36% YoY), and the FY2025 full-year result was $1.9 million, up 147.53% from the prior year.
- Income from Non-Controlling Interests for Q1 2026 stood at -$350000.0, down from -$84000.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $1.4 million in Q2 2025, with the low at -$350000.0 in Q1 2026.
- Historically, Income from Non-Controlling Interests has averaged $302823.5 across 5 years, with a median of $290000.0 in 2023.
- Annual changes were most pronounced in 2025 — Income from Non-Controlling Interests surged 568.45% — and 2026, when it tumbled 468.42%.
- Green Thumb Industries' Income from Non-Controlling Interests stood at $317000.0 in 2022, then declined by 5.05% to $301000.0 in 2023, then plunged by 58.47% to $125000.0 in 2024, then sank by 167.2% to -$84000.0 in 2025, then plunged by 316.67% to -$350000.0 in 2026.
- The last three Income from Non-Controlling Interests figures came in at -$350000.0 (Q1 2026), -$84000.0 (Q4 2025), and $513000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 22.56 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Green Thumb Industries | - | - | 143.65 Mn | -350,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -350,000.00 |
| Dec 31, 2025 | -84,000.00 |
| Sep 30, 2025 | 513,000.00 |
| Jun 30, 2025 | 1.38 Mn |
| Mar 31, 2025 | 95,000.00 |
| Dec 31, 2024 | 125,000.00 |
| Sep 30, 2024 | 165,000.00 |
| Jun 30, 2024 | 206,000.00 |
| Mar 31, 2024 | 272,000.00 |
| Dec 31, 2023 | 301,000.00 |
| Sep 30, 2023 | 295,000.00 |
| Jun 30, 2023 | 290,000.00 |
| Mar 31, 2023 | 266,000.00 |
| Dec 31, 2022 | 317,000.00 |
| Sep 30, 2022 | 319,000.00 |
| Jun 30, 2022 | 294,000.00 |
| Mar 31, 2022 | 747,000.00 |
| Dec 31, 2021 | 1.24 Mn |
| Sep 30, 2021 | 1.38 Mn |
| Jun 30, 2021 | 1.22 Mn |